Program 2022

Monday, May 2, 2022

12:00-13:00 General Assembly (by invitation only)
Room Sydney
12:30 Registration opens
Entrance
13:00-14:00 Press Conference
Room Rio
13:00-18:00 Partnering and Global Village with Round Table Discussions throughout the day
Room San Francisco
Welcome to the Global Village at the Swiss Biotech Day 2022.

The Global Village is hosted by the Swiss Biotech Association and Switzerland Global Enterprise. In the Global Village we want to strengthen bilateral relationships between the country delegation and Switzerland. Please join us for roundtable discussions, aiming to facilitate partnerships and connect international representatives with the Swiss biotech industry for research, corporate collaborations, policy-making and investments.

 

We at Switzerland Global Enterprise support Swiss SMEs in their international business and help innovative foreign companies to establish an operation in Switzerland. Whether goods or services, start-up or seasoned exporter, we provide information, services and contacts for your entire internationalization process.

 

Join us at a bilateral roundtable discussion or have a drink with us at the international reception in the Global Village and network with the global biotech community!

presented by

16:00 – 18:00 Round Table Discussions

16:00: China/Hong Kong – What are the essential keys to having Swiss-Sino cooperation with real impacts?

16:45: Greece – Partnering with the Greek Bio industry ecosystem: Opportunities for Innovation and Growth

17:30: South Carolina – South Carolina, USA and Switzerland: Opportunities for partnership, collaboration and growth in the Life Sciences Sector

13:00-19:00 Exhibition throughout the day
Foyer 2nd and 3rd Floor
14:00-15:30 Plenary Session
Room Sydney

Moderator: Monika Jones

14:00 Welcome Address
Michael Altorfer, CEO, Swiss Biotech Association
Jo Vergeat, president of the parliament of the Canton of Basel-Stadt
14:15 Opening Key Note by the President of the Swiss Confederation Ignazio Cassis

Ignazio Cassis worked as a medical doctor before starting his political career as a member of the communal parliament for Collina d’Oro, in the district of Lugano. Whilst serving as the cantonal physician, he was elected 2007 to the National Council as a member of the FDP. In 2017, Ignazio Cassis was elected to the Federal Council and took up his post as head of the Federal Department of Foreign Affairs (FDFA). In 2022, he assumed the presidency of the Swiss Confederation.

14:45 Institute of Molecular and Clinical Ophthalmology Basel (IOB), Wyss Center Zürich, two prime examples of Public Private Partnerships 

Introduction to the presentation of the Institute of Molecular and Clinical Ophthalmology Basel (IOB)

  • Bernhard Maag, Business Franchise Head Ophthalmology a.i., Novartis
  • Dr. Charles Gubser, GPH Excellence Head Novartis, Secretary of IOB’s Board of Trustees

IOB presentation: “IOB – a novel concept for translational research”

  • Prof. Botond Roska, IOB Founding Director – Molecular Research
  • Prof. Hendrik Scholl, IOB Founding Director – Clinical Research, Chairman and Chief Physician of the Eye Clinic at University Hospital Basel (virtual participation)

Panel: “Institute of Molecular and Clinical Ophthalmology Basel (IOB), Wyss Center Zürich, two prime examples of Public Private Partnerships”

  • Dr. Charles Gubser, GPH Excellence Head Novartis, Secretary of IOB’s Board of Trustees
  • Prof. Botond Roska, IOB Founding Director – Molecular Research
  • Prof. Hendrik Scholl, IOB Founding Director – Clinical Research, Chairman and Chief Physician of the Eye Clinic at University Hospital Basel (virtual participation)
  • Prof. Simon Hoerstrup, Founding Co-Director Wyss Center Zurich
15:15-15:45 Coffee Break
15:30-18:30 Parallel Tracks

Moderator: Daniel Chancellor

15:30 – 15:45

15:45 – 16:00

16:00 – 16:15

16:15 – 16:30

16:30 – 16:45

16:45 – 17:00

17:00 – 17:15

17:15 – 17:30

17:30 – 17:45

17:45 – 18:00

18:00 – 18:15

18:15 – 18:30

Pharma Intelligence

Catalent

CSEM

Benchling

Unicyte AG

break

Philip Morris Switzerland

Aequitec AG

Helbling Technik AG

Valgenesis

InvestHK

VirdisGroup

presented by

Moderator: Dominik Escher, Pureos Bioventures

15:30 – 15:45

15:45 – 16:00

16:00 – 16:15

16:15 – 16:30

16:30 – 16:45

16:45 – 17:00

17:00 – 17:15

17:15 – 17:30

17:30 – 17:45

Pureos Bioventures

Tolremo

Nanolive

GliaPharm

Artidis

Haya Therapeutics

Ab2 Bio

Perseo Pharma

MPC Therapeutics

presented by

15:30 – 15:45

15:45 – 16:00

16:00 – 16:15

16:15 – 16:30

16:30 – 16:45

16:45 – 17:00

Rentschler Biopharma

Addex Therapeutics

Oryzon Genomics

BioVersys

GeNeuro SA

Swati AG

presented by

17:45 – 18:30 Discover the Venture Leaders Biotech opportunities 

Successful Venture Leaders alumni Ulf Grawunder will share his experience in building and selling NBE Therapeutics, a 1.1 bn exit, followed by pitches of selected biotech startups.

presented by

17:45 Opening and Venture Leaders Biotech  introduction
17:50 Presentation by and discussion with alumni Ulf Grawunder:
From start to 1 billion exit
18:00 SEED Biosciences Isolate single cells reliably and cost-effectively
18:04 MaxWell Biosystems AG High-Content electrophysiology platforms
18:08 EraCal Therapeutics AG We develop the next generation anti-obesity drug
18:12 InterAx Biotech AG Reinventing GPCR drug discovery
18:16 Adiposs Imaging Body Fat – Saving Lives
18:20 Muvon Therapeutics Cell therapy for the regeneration of skeletal muscle tissue
18:24 Closing word with Bertrand Ducrey , CEO Debiopharm
18:00-19:00 International Reception
Room San Francisco
18:30-21:00 Evening Reception
Foyer 2nd Floor

sponsored by

Tuesday, May 3, 2022

07:30 Registration opens
Entrance
08:00-16:00 Partnering and Global Village with Round Table Discussions throughout the day
Room San Francisco
Welcome to the Global Village at the Swiss Biotech Day 2022.

The Global Village is hosted by the Swiss Biotech Association and Switzerland Global Enterprise. In the Global Village we want to strengthen bilateral relationships between the country delegation and Switzerland. Please join us for roundtable discussions, aiming to facilitate partnerships and connect international representatives with the Swiss biotech industry for research, corporate collaborations, policy-making and investments.

 

We at Switzerland Global Enterprise support Swiss SMEs in their international business and help innovative foreign companies to establish an operation in Switzerland. Whether goods or services, start-up or seasoned exporter, we provide information, services and contacts for your entire internationalization process.

 

Join us at a bilateral roundtable discussion or have a drink with us at the international reception in the Global Village and network with the global biotech community!

12:30 – 16:00 Round Table Discussions

12:30: Catalonia – New ways of working together

13:15: Canada – Cyber Security, AI and Big Data Analysis: The Opportunities

14:00: Turkey– The role and contribution of Turkey in R&D and clinical trials

14:45: France/Biovalley – How to strengthen the French-Swiss relations in the biotech world?

15:30: India – From startups to the role of government: What are the pressing developments between India and Switzerland?

09:00-16:00 Exhibition throughout the day
Foyer 2nd and 3rd Floor
09:30-11:30 Plenary Session
Room Sydney

Moderator: Monika Jones

09:30 Welcome Address
Michael Altorfer, CEO, Swiss Biotech Association
09:35 Making healthcare more personal & digital – partnering across the ecosystem
Christian Gossens, Global Area Head Digital Biomarkers, Pharma Research & Early Development (pRED) Data and Analytics at Roche
Valerie Hepp, Digital and PHC Pharma Partnering Europe & Asia Lead at Roche
Prof. Dr. Sven Hirsch, Director of ZHAW D
igital Health Lab

10:10 Covid 19 Therapeutics, Molecular Partners/Novartis
10:45 Lighthouse – A public-private partnership for Pandemic Preparedness
Andrin Oswald, Co-Initiator
11:00 Swiss Biotech Report 2022
Frederik Schmachtenberg, PhD, Partner, Global Life Sciences Lead for Financial Accounting Advisory Services, EY
11:15 Swiss Biotech Success Stories Award
Luca Bolliger, jury president
11:30-12:30 Lunch
Foyer 2nd and 3rd Floor
12:30-16:00 Parallel Tracks

Moderator: Daniel Chancellor

12:30 – 12:45

12:45 – 13:00

13:00 – 13:15

13:15 – 13:30

13:30 – 13:45

13:45 – 14:00

14:00 – 14:15

14:15 – 14:30

14:30 – 14:45

Pharma Intelligence

Charles River

Medicilon Inc.

DyNAbind

Aragen

IQVIA Biotech

Catalent

SciNote

PackGene

presented by

14:50 – 15:00

15:00 – 15:15

15:15 – 15:30

15:30 – 15:45

15:45 – 16:00

Rentschler Biopharma

Xlife Sciences

Rejuveron

IPS Biopharma AG

Molecular Partners AG

presented by

Moderator: Martin Münchbach, Pureos Bioventures

12:30 -12:45

12:45 – 13:00

13:00 – 13:15

13:15 – 13:30

13:30 – 13:45

13:45 – 14:00

14:00 – 14:15

14:15 – 14:30

14:30 – 14:45

14:45 – 15:00

15:00 – 15:15

15:15 – 15:30

15:30 – 15:45

15:45 – 16:00

CDR Life

Deep Breath Intelligence

InSphero

Scailyte

Acthera

Pharma Biome

Synendos

Gnubiotics

Clemedi

Engimmune Therapeutics

Aukera Therapeutics

Ridgeline Discovery

Hemotune

Cimeio Therapeutics

presented by

14:30 – 15:15 Panel 15: Talent Shortage – Our way to stand out presented by

15:30 – 16:15 Panel 16: Attract & retain talents presented by Swiss Biotech Association
14:30-15:00 Coffee Break
16:00-18:00 Evening Reception
Foyer 2nd and 3rd Floor

sponsored by

More details will be announced soon. Subject to change without notice.